Medical corporation keizukai Chayamachi Ladies Clinic
Osaka, Japan
Gynecologist in Osaka
〒530-0013 Osaka, Kita Ward, Chayamachi, 2−19 JPR茶屋町ビル 4階
About Medical corporation keizukai Chayamachi Ladies Clinic
"日曜日はピル科のみ診療（婦人科は休診）です。"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Medical corporation keizukai Chayamachi Ladies Clinic
During the past decade, Medical corporation keizukai Chayamachi Ladies Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
2003-06-01
2022-12-22
Completed
588
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Medical corporation keizukai Chayamachi Ladies Clinic
According to Clinical.Site data, the most researched conditions in "Medical corporation keizukai Chayamachi Ladies Clinic" are
"Leiomyoma" (1 trials) and "Uterine Fibroids and Heavy Menstrual Bleeding" (1 trials). Many other conditions were trialed in "Medical corporation keizukai Chayamachi Ladies Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Medical corporation keizukai Chayamachi Ladies Clinic
Most popular intervention types in "Medical corporation keizukai Chayamachi Ladies Clinic" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Vilaprisan (BAY1002670)" (2 trials) and "Standard of care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical corporation keizukai Chayamachi Ladies Clinic
The vast majority of trials in "Medical corporation keizukai Chayamachi Ladies Clinic" are
2 trials for "Female" genders.
Clinical Trials Status at Medical corporation keizukai Chayamachi Ladies Clinic
Currently, there are NaN active trials in "Medical corporation keizukai Chayamachi Ladies Clinic".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Medical corporation keizukai Chayamachi Ladies Clinic,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medical corporation keizukai Chayamachi Ladies Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".